Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Venture Capital Deals
CNN / Google News ^ | June 14, 2012 | CNN Financial Staff

Posted on 06/16/2012 2:18:45 PM PDT by IsraelBeach

Global Blood Therapeutics Inc., a San Francisco-based developer of oral medicines to treat chronic blood-based diseases, has launched with $40.7 million in Series A funding from Third Rock Ventures. www.globalbloodtx.com

Invuity, a San Francisco-based developer of surgical visualization and illumination technology, has raised $25 million in Series D funding. Valence Advantage led the round, and was joined by return backers Kleiner Perkins Caufield & Byers and InterWest Partners. www.invuity.com

Thismoment, a San Francisco-based provider of social content management software for brands, has raised $22 million in Series C funding led by Trident Capital. The company previously raised over $11 million by firms like Sierra Ventures. www.thismoment.com

(Excerpt) Read more at finance.fortune.cnn.com ...


TOPICS: Business/Economy; Israel; US: California; US: New York
KEYWORDS: business; funding; vc; venturecapital

1 posted on 06/16/2012 2:18:54 PM PDT by IsraelBeach
[ Post Reply | Private Reply | View Replies]

To: IsraelBeach

Social networking is a poor excuse for an industry but whatever.


2 posted on 06/16/2012 2:59:25 PM PDT by the invisib1e hand (they have no god but caesar)
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson